Ceramide Kinase Inhibition Drives Ferroptosis and Sensitivity to Cisplatin in Mutant KRAS Lung Cancer by Dysregulating VDAC-Mediated Mitochondria Function.

Find People
Find Research
Overview
Tutorials
FAQs
Edit My PROFILE
Login to PROFILES

History

Approaches to the stud

Cast, Thomas

Ceramide Kinase Inhibi

Optic Atrophy, Autosom

Proinsulin/Insulin aut

See All (5) pages

Contact Us
If you have any questions or feedback please contact us.

Ceramide Kinase Inhibition Drives Ferroptosis and Sensitivity to Cisplatin in Mutant KRAS Lung Cancer by Dysregulating VDAC-Mediated Mitochondria Function.

Vu NT, Kim M, Stephenson DJ, MacKnight HP, Chalfant CE. Ceramide Kinase Inhibition Drives Ferroptosis and Sensitivity to Cisplatin in Mutant KRAS Lung Cancer by Dysregulating VDAC-Mediated Mitochondria Function. Mol Cancer Res. 2022 09 02; 20(9):1429-1442.

View in: PubMed

subject areas

Animals
Carcinoma, Non-Small-Cell Lung
Ceramides
Cisplatin
Lung Neoplasms
Mammals
Mitochondria
Phosphotransferases (Alcohol Group Acceptor)
Proto-Oncogene Proteins p21(ras)

authors with profiles

Daniel J Stephenson

Contact Us
CCTSI
About CCTSI
CCTSI Affiliated Institutions
National CTSA Consortium